Literature DB >> 20551261

The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results.

Karin J Denton1, Christine Bergeron, Petra Klement, Marcus J Trunk, Thomas Keller, Ruediger Ridder.   

Abstract

We analyzed the performance of p16(INK4a) immunocytochemistry on a series of 810 retrospectively collected atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL) cases with available biopsy follow-up data, including 94 cases of cervical intraepithelial neoplasia (CIN) 2 and 128 cases of CIN 3. Human papillomavirus (HPV) testing was performed from the same residual liquid-based cytologic specimen, and results for both tests were correlated with histologic follow-up data. Sensitivity values for high-grade CIN (HGCIN) confirmed on biopsy within 6 months were 92.6% (ASC-US) and 92.2% (LSIL) for cytotechnologists' reviews of p16 cytology and 90.1% (ASC-US) and 95.7% (LSIL) for HPV testing. Sensitivity rates of initial pathologists' reviews were slightly lower, 76.4% to 80.1%, with levels comparable to cytotechnologists' results after adjudication. The specificity of p16 cytology for HGCIN detection was significantly higher than for HPV testing for cytotechnologists and pathologists: 63.2% to 71.1% (p16 cytology) vs 37.8% for HPV in ASC-US (P < .001) and 37.3% to 53.3% (p16 cytology) vs 18.5% for HPV in LSIL (P < .001). This evaluation of the diagnostic performance of p16 cytology confirms the potential of this stain for the efficient triage of ASC-US and LSIL cytologic results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20551261     DOI: 10.1309/AJCP3CD9YKYFJDQL

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  29 in total

Review 1.  Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.

Authors:  Vikrant V Sahasrabuddhe; Patricia Luhn; Nicolas Wentzensen
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

Review 2.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

3.  On-chip immunofluorescence analysis of single cervical cells using an electroactive microwell array with barrier for cervical screening.

Authors:  Makoto Takeuchi; Kazunori Nagasaka; Mina Yoshida; Yoshiko Kawata; Yuko Miyagawa; Saori Tago; Haruko Hiraike; Osamu Wada-Hiraike; Katsutoshi Oda; Yutaka Osuga; Tomoyuki Fujii; Takuya Ayabe; Soo Hyeon Kim; Teruo Fujii
Journal:  Biomicrofluidics       Date:  2019-07-30       Impact factor: 2.800

4.  Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.

Authors:  Anne Szarewski; David Mesher; Louise Cadman; Janet Austin; Lesley Ashdown-Barr; Linda Ho; George Terry; Stuart Liddle; Martin Young; Mark Stoler; Julie McCarthy; Corrina Wright; Christine Bergeron; W P Soutter; Deirdre Lyons; Jack Cuzick
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

Review 5.  [Modern biomarkers for precancerous lesions of the uterine cervix : Histological-cytological correlation and use].

Authors:  D Schmidt
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

6.  Claudin-1 as a Biomarker of Cervical Cytology and Histology.

Authors:  Márta Benczik; Ádám Galamb; Róbert Koiss; Attila Kovács; Balázs Járay; Tamás Székely; Tímea Szekerczés; Zsuzsa Schaff; Gábor Sobel; Csaba Jeney
Journal:  Pathol Oncol Res       Date:  2016-01       Impact factor: 3.201

Review 7.  Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.

Authors:  Megan A Clarke; Nicolas Wentzensen; Lisa Mirabello; Arpita Ghosh; Sholom Wacholder; Ariana Harari; Attila Lorincz; Mark Schiffman; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-03       Impact factor: 4.254

8.  Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia.

Authors:  Lisa Mirabello; Mark Schiffman; Arpita Ghosh; Ana C Rodriguez; Natasa Vasiljevic; Nicolas Wentzensen; Rolando Herrero; Allan Hildesheim; Sholom Wacholder; Dorota Scibior-Bentkowska; Robert D Burk; Attila T Lorincz
Journal:  Int J Cancer       Date:  2012-08-20       Impact factor: 7.396

9.  Optimizing technology for cervical cancer screening in high-resource settings.

Authors:  Lyndsay A Richardson; Joseph Tota; Eduardo L Franco
Journal:  Expert Rev Obstet Gynecol       Date:  2011-05

10.  Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.

Authors:  Takuma Fujii; Miyuki Saito; Toshihiko Hasegawa; Takashi Iwata; Hiroyuki Kuramoto; Kaneyuki Kubushiro; Mineo Ohmura; Kazunori Ochiai; Hiroharu Arai; Masaru Sakamoto; Teiichi Motoyama; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2014-04-18       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.